Virtual Medicinal Product (VMP) - Adrenaline (base) 1mg/10ml (1 in 10,000) dilute solution for injection ampoules

Navigation

Name Details

Name Start Date End Date
Name Current Name Adrenaline (base) 1mg/10ml (1 in 10,000) dilute solution for injection ampoules Start Date 28-02-2012 End Date
Previous Name Previous Name Adrenaline acid tartrate 1mg/10ml (1 in 10,000) solution for injection ampoules Start Date 16-06-2004 End Date 27-02-2012
Abbreviated Name Abbreviated Name Adrenaline (base) 1mg/10ml (1 in 10,000) dilute inj ampoules Start Date 28-02-2012
Previous Abbreviated Name Adrenaline acid tartrate 1mg/10ml (1 in 10,000) inj ampoules Previous Start Date 01-05-2009 Previous End Date 26-02-2012

Unit Dose & Form Information

DF Indicator
Discrete
UDFS Indicator
10
UDFS UOM
ml
Unit Dose UOM
ampoule

Summary

Prescribing Status
Valid as a prescribable product
Controlled Drug Category
No Controlled Drug Status
Route
Intravenous, Intraosseous
Form
Solution for injection
Ontology Form/Route
solutioninjection.intravenous, solutioninjection.intraosseous
Name Basis
BANM - British Approved Name (Modified)

Codes

ATC Code
C01CA24
BNF Start Date End Date
Current BNF 02070300 Start Date 04-04-2022 End Date
Previous BNF 03040300 Start Date 01-02-2005 End Date 03-04-2022
Previous BNF 02070300 Start Date 01-02-2005 End Date 03-04-2022
SNOMED Codes
Code Start Date End Date
35894911000001108 17-10-2018
319489008 16-06-2003 16-10-2018

VMP Ingredients

VMP ingredients table
Name Basis of Strength Description BOSS Strength and UOM (Nmr) Strength and UOM (Dmr)
Adrenaline acid tartrate Based on Base Substance Adrenaline 100 microgram 1 ml

Parent Products

Virtual Medicinal Product Pack (VMPP) Information

Pack Size Drug Tariff Price Drug Tariff Payment Category
1 ampoule
10 ampoule 15708 Part VIIIA Category C